Skip to main content
. Author manuscript; available in PMC: 2017 Jun 5.
Published in final edited form as: J Am Coll Cardiol. 2015 Aug 11;66(6):645–655. doi: 10.1016/j.jacc.2015.06.022

Table 2.

Unadjusted and adjusted regression coefficients for female sex predicting the percentage of years of potential life lost*

Model B (SE) for Female Sex p-value
Unadjusted 0.105 (0.003) <0.001
 + Age, race 0.096 (0.003) <0.001
 + Age, race, medical history 0.084 (0.003) <0.001
 + Age, race, medical history, clinical presentation§ 0.092 (0.003) <0.001
 + Age, race, medical history, clinical presentation, treatment|| 0.078 (0.002) <0.001
*

The intercept for male sex in the unadjusted model was 0.418 (SE 0.002), indicating that men lost on average 41.8% of their remaining life after AMI.

Parameter estimates reflect average difference in life expectancy for women compared with men. For example, prior to adjustment, women lost on average 10.5% more (or 52.3% total) of their remaining life after AMI than men.

Medical history covariates include history of chronic heart failure, diabetes mellitus hypertension, coronary artery disease, and smoking.

§

Clinical presentation covariates include anterior AMI, ST-segment elevation AMI, cardiac arrest, Killip class, and renal insufficiency.

||

Treatment covariates include revascularization within 30 days, fibrinolytic therapy, aspirin and beta-blockers at arrival.